Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 …
A Kukulska, J Krajewska, M Gawkowska-Suwińska… - Thyroid research, 2010 - Springer
Background The aim of this study is to compare the effectiveness of 131 I therapy between
three groups of DTC patients who received 30, 60 or 100 mCi for thyroid remnant ablation …
three groups of DTC patients who received 30, 60 or 100 mCi for thyroid remnant ablation …
131I Activity for Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Systematic Review
A Hackshaw, C Harmer, U Mallick… - The Journal of …, 2007 - academic.oup.com
Context: Radioiodine ablation of the thyroid remnant after thyroidectomy is commonly
performed in the management of patients with differentiated thyroid cancer. Although many …
performed in the management of patients with differentiated thyroid cancer. Although many …
Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients
CS Bal, A Kumar, GS Pant - The Journal of Clinical …, 2004 - academic.oup.com
Remnant ablation can be achieved by either administering an empiric fixed dose or using
dosimetry-guided techniques. Because of the technical and logistic difficulties, most centers …
dosimetry-guided techniques. Because of the technical and logistic difficulties, most centers …
Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: a comparison of ablation success with different activities of …
Objective To assess efficiency of various I-131 activities on thyroid remnant ablation in
thyroid cancer patients. The significance of patients' characteristics, pathologic features and …
thyroid cancer patients. The significance of patients' characteristics, pathologic features and …
Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer
M Caglar, FM Bozkurt, CK Akca, SE Vargol… - Nuclear medicine …, 2012 - journals.lww.com
Results When three tests were used to define successful ablation, in group L, 32 out of 53
(60%) and 43 out of 53 (81%) patients were successfully treated versus 35 out of 55 (64%) …
(60%) and 43 out of 53 (81%) patients were successfully treated versus 35 out of 55 (64%) …
Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial
Objectives Radioiodine ablation of thyroid tissue remains the cornerstone of treatment for
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose …
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose …
Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid …
EY Kim, TY Kim, WG Kim, JH Yim, JM Han… - Nuclear Medicine …, 2011 - journals.lww.com
Objectives The aim of this study was to compare ablation success and disease-free survival
(DFS) on the basis of different ablation doses. Methods This retrospective study enrolled …
(DFS) on the basis of different ablation doses. Methods This retrospective study enrolled …
Prospective randomised trial for the evaluation of the efficacy of low vs. high dose I-131 for post operative remnant ablation in differentiated thyroid cancer
S Sirisalipoch, V Buachum, P Pasawang… - World Journal of …, 2004 - inis.iaea.org
[en] This study was performed under the auspices of IAEA project (i) to evaluate the efficacy
of low (50 mCi) vs. high (100 mCi) dose I-131 for post operative remnant ablation in …
of low (50 mCi) vs. high (100 mCi) dose I-131 for post operative remnant ablation in …
Thyroid Remnant 131I Ablation for Papillary and Follicular Thyroid Carcinoma
EL Mazzaferri - Thyroid, 1997 - liebertpub.com
Outcome was compared in 1004 patients with differentiated thyroid carcinoma (DTC) who
underwent thyroid remnant ablation with 131I (n= 151) or were either treated with thyroid …
underwent thyroid remnant ablation with 131I (n= 151) or were either treated with thyroid …
Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited
Postoperative ablation of functioning thyroid tissue has become established in the
management of differentiated thyroid cancer as the long-term risk of recurrence and death is …
management of differentiated thyroid cancer as the long-term risk of recurrence and death is …